Leap Therapeutics, Inc.
LPTX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $18,816 | $12,305 | $12,591 | $118,806 |
| - Cash | $26,762 | $18,130 | $32,713 | $47,249 |
| + Debt | $3,313 | $39 | $154 | $266 |
| Enterprise Value | -$4,633 | -$5,786 | -$19,968 | $71,823 |
| Revenue | $209 | $0 | $0 | $234 |
| % Growth | – | – | -100% | – |
| Gross Profit | -$20,130 | $0 | $0 | -$10,440 |
| % Margin | -9,631.6% | – | – | -4,461.5% |
| EBITDA | -$25,184 | -$16,636 | -$15,429 | -$20,193 |
| % Margin | -12,049.8% | – | – | -8,629.5% |
| Net Income | -$25,969 | -$16,643 | -$15,435 | -$40,169 |
| % Margin | -12,425.4% | – | – | -17,166.2% |
| EPS Diluted | -0.08 | -0.4 | -0.37 | -0.37 |
| % Growth | 80% | -8.1% | 0% | – |
| Operating Cash Flow | -$16,292 | -$14,486 | -$14,480 | -$15,512 |
| Capital Expenditures | -$1,992 | $0 | $0 | $0 |
| Free Cash Flow | -$18,284 | -$14,486 | -$14,480 | -$15,512 |